|
Integrated Network Pharmacology and Antioxidant Activity-Guided Screen System to Exploring Antioxidants and Quality Markers of Shunaoxin Pills against Chronic Cerebral Ischemia |
|
View Full Text View/Add Comment Download reader |
DOI:10.4103/wjtcm.wjtcm_5_19 |
KeyWord:Antioxidant, chronic cerebral ischemia, network
pharmacology, Q-markers, Shunaoxin pills |
Author | Institution |
Nian-Wei Changa |
a.Graduate School, Tianjin University of Traditional Chinese Medicine |
Dan-Dan Chenga |
a.Graduate School, Tianjin University of Traditional Chinese Medicine |
Jia-Nan Nia |
a.Graduate School, Tianjin University of Traditional Chinese Medicine |
Ying-Ying Guoa |
a.Graduate School, Tianjin University of Traditional Chinese Medicine |
Guang-Cui Chu a |
a.Graduate School, Tianjin University of Traditional Chinese Medicine |
Unchol Kimbc |
b.College of Pharmacy, State Key Laboratory of Medicinal Chemical Biology,Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People’s Republic of China;c.Department of Genetic Engineering,State Academy of Sciences, Pyongyang, Democratic People’s Republic of Korea |
Min Jiangb |
b.College of Pharmacy, State Key Laboratory of Medicinal Chemical Biology,Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People’s Republic of China |
Gang Baib |
b.College of Pharmacy, State Key Laboratory of Medicinal Chemical Biology,Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People’s Republic of China |
|
Hits: 1423 |
Download times: 1748 |
Abstract: |
Objective: The main objective of the study is to screen the quality markers (Q-markers) for relieving oxidative stress damage and against chronic
cerebral ischemia in Shunaoxin pills (SNX). Methods: The benefit effect of SNX was evaluated by a rat chronic cerebral ischemia model. The main
ingredients of SNX were identified by ultra-performance liquid chromatography-quadrupole time-of-flight, whereas its core targets and pathways around
antioxidative stress were predicted by PharmMapper and kyoto encyclopedia of genes and genomes (KEGG) analysis. Moreover, the antioxidants
were screened by high-performance liquid chromatography with postcolumn derivatization system and then representative ingredients were verified
by cell experiments. Results: SNX could increase expression of catalase and superoxide dismutase (SOD) as well as antagonize oxidative damage
in the brain. The effects may be related to three types of antioxidant pathways, including nitrogen metabolism, arachidonic acid metabolism, and the
cyclic guanosine monophosphate-dependent protein kinase (cGMP-PKG) signaling pathway by multiple active components regulate targets. Among
them, ferulic acid and ligustilide were shown the key scavenging ability for reactive oxygen free radicals and significantly increased the contents of
nitric oxide (NO), NO synthase, and SOD as well as decreased malonaldehyde. Conclusion: The oxidation resistances of biological and chemical
processes in SNX to protect against cerebral oxidative stress injury were preliminary revealed by an integrated network pharmacology and antioxidant
activity-guided screen system. Ferulic acid and ligustilide played a major antioxidant role that could be used as Q-markers to control the quality of SNX. |
Close |
|
|
|